An investigation of LAG3+ T-cells in pediatric cHL using IHC on patients treated on the COG AHOD0031 revealed that 73/115 (63%) of the baseline pediatric cHL tumors demonstrated LAG3+ staining in the TME (60). Here, LAG3 is linked to classic Hodgkin lymphoma.